Cargando…

Camptocormia in Parkinson's Disease

Objectives. Abnormalities of posture represent one of the main features of Parkinson's disease (PD). Among them, camptocormia has been considered as rare in PD. We investigated frequency and clinical features of camptocormia in PD patients. Methods. 153 PD patients (mean 68.5 ± 10.7 years old,...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Kazuo, Uchida, Yutaka, Notani, Masaru
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951140/
https://www.ncbi.nlm.nih.gov/pubmed/20948888
http://dx.doi.org/10.4061/2010/267640
_version_ 1782187692066340864
author Abe, Kazuo
Uchida, Yutaka
Notani, Masaru
author_facet Abe, Kazuo
Uchida, Yutaka
Notani, Masaru
author_sort Abe, Kazuo
collection PubMed
description Objectives. Abnormalities of posture represent one of the main features of Parkinson's disease (PD). Among them, camptocormia has been considered as rare in PD. We investigated frequency and clinical features of camptocormia in PD patients. Methods. 153 PD patients (mean 68.5 ± 10.7 years old, duration 5.9 ± 2.4 years) outpatiently recruited. After neurologic examination, patients were rated on the Unified PD Rating Scale motor scale (UPDRS Part III), minimental state examination (MMSE). Also we evaluated patients with camptocormia by MRI. Of the 153 PD patients, 27 had camptocormia (mean age, 67.9 ± 7.9 years old; disease duration, 6.1 ± 3.9 years). For further evaluation, we recruited age- and sex-matched 27 PD patients without camptocormia (11 men and 16 women; mean age ±  SD, 69.2 ± 10.1 years, duration 6.0 ± 2.7 years) These selected 54 patients completed several self-assessments. Lumbar and thoracic paraspinal muscles were studied by EMG. Results. There were no significant differences in age, duration, severity, and drug dose between patients with and without camptocormia. Analysis of NMSS subitems indicated that PD patients tended to show lower scores for sleep/fatigue, attention/memory, and miscellaneous items. Conclusions. We found significant differences concerning nonmotor signs and symptoms evaluated by FAB, PDQ-8, FSQ, VAS-F, and NMSS between patients with and without camptocormia. Our findings indicate that camptocormia is a relatively common sign in PD and that patients with camptocormia scores on the PDQ-8 compared with PD patients without camptocormia. This suggests that improvements in camptocormia of PD patients may improve their QOL.
format Text
id pubmed-2951140
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher SAGE-Hindawi Access to Research
record_format MEDLINE/PubMed
spelling pubmed-29511402010-10-14 Camptocormia in Parkinson's Disease Abe, Kazuo Uchida, Yutaka Notani, Masaru Parkinsons Dis Research Article Objectives. Abnormalities of posture represent one of the main features of Parkinson's disease (PD). Among them, camptocormia has been considered as rare in PD. We investigated frequency and clinical features of camptocormia in PD patients. Methods. 153 PD patients (mean 68.5 ± 10.7 years old, duration 5.9 ± 2.4 years) outpatiently recruited. After neurologic examination, patients were rated on the Unified PD Rating Scale motor scale (UPDRS Part III), minimental state examination (MMSE). Also we evaluated patients with camptocormia by MRI. Of the 153 PD patients, 27 had camptocormia (mean age, 67.9 ± 7.9 years old; disease duration, 6.1 ± 3.9 years). For further evaluation, we recruited age- and sex-matched 27 PD patients without camptocormia (11 men and 16 women; mean age ±  SD, 69.2 ± 10.1 years, duration 6.0 ± 2.7 years) These selected 54 patients completed several self-assessments. Lumbar and thoracic paraspinal muscles were studied by EMG. Results. There were no significant differences in age, duration, severity, and drug dose between patients with and without camptocormia. Analysis of NMSS subitems indicated that PD patients tended to show lower scores for sleep/fatigue, attention/memory, and miscellaneous items. Conclusions. We found significant differences concerning nonmotor signs and symptoms evaluated by FAB, PDQ-8, FSQ, VAS-F, and NMSS between patients with and without camptocormia. Our findings indicate that camptocormia is a relatively common sign in PD and that patients with camptocormia scores on the PDQ-8 compared with PD patients without camptocormia. This suggests that improvements in camptocormia of PD patients may improve their QOL. SAGE-Hindawi Access to Research 2010-06-30 /pmc/articles/PMC2951140/ /pubmed/20948888 http://dx.doi.org/10.4061/2010/267640 Text en Copyright © 2010 Kazuo Abe et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Abe, Kazuo
Uchida, Yutaka
Notani, Masaru
Camptocormia in Parkinson's Disease
title Camptocormia in Parkinson's Disease
title_full Camptocormia in Parkinson's Disease
title_fullStr Camptocormia in Parkinson's Disease
title_full_unstemmed Camptocormia in Parkinson's Disease
title_short Camptocormia in Parkinson's Disease
title_sort camptocormia in parkinson's disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951140/
https://www.ncbi.nlm.nih.gov/pubmed/20948888
http://dx.doi.org/10.4061/2010/267640
work_keys_str_mv AT abekazuo camptocormiainparkinsonsdisease
AT uchidayutaka camptocormiainparkinsonsdisease
AT notanimasaru camptocormiainparkinsonsdisease